TY - JOUR
T1 - Catalyzing transcriptomics research in cardiovascular disease
T2 - The CardioRNA COST action CA17129
AU - EU-CardioRNA COST Action (CA17129)
AU - da Costa Gomes, Clarissa Pedrosa
AU - Ágg, Bence
AU - Andova, Andrejaana
AU - Arslan, Serdal
AU - Baker, Andrew
AU - Barteková, Monika
AU - Beis, Dimitris
AU - Betsou, Fay
AU - Wettinger, Stephanie Bezzina
AU - Bugarski, Branko
AU - Condorelli, Gianluigi
AU - da Silva, Gustavo José Justo
AU - Danilin, Sabrina
AU - de Gonzalo-Calvo, David
AU - Buil, Alfonso
AU - Carmo-Fonseca, Maria
AU - Enguita, Francisco J.
AU - Felekkis, Kyriacos
AU - Ferdinandy, Peter
AU - Gyöngyösi, Mariann
AU - Hackl, Matthias
AU - Karaduzovic-Hadziabdic, Kanita
AU - Hellemans, Jan
AU - Heymans, Stephane
AU - Hlavackova, Markéta
AU - Hoydal, Morten Andre
AU - Jankovic, Aleksandra
AU - Jusic, Amela
AU - Kardassis, Dimitris
AU - Kerkelä, Risto
AU - Kuster, Gabriela M.
AU - Lakkisto, Päivi
AU - Leszek, Przemyslaw
AU - Lustrek, Mitja
AU - Maegdefessel, Lars
AU - Martelli, Fabio
AU - Novella, Susana
AU - O'Brien, Timothy
AU - Papaneophytou, Christos
AU - Pedrazzini, Thierry
AU - Pinet, Florence
AU - Popescu, Octavian
AU - Potočnjak, Ines
AU - Robinson, Emma
AU - Sasson, Shlomo
AU - Scholz, Markus
AU - Simionescu, Maya
AU - Stoll, Monika
AU - Varga, Zoltan V.
AU - Vinciguerra, Manlio
N1 - Publisher Copyright:
© 2018 by the authors.
PY - 2019
Y1 - 2019
N2 - Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).
AB - Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).
KW - Best practices and guidelines
KW - Cardiovascular disease
KW - Personalized medicine
KW - Transcriptomics
KW - Translational research
UR - http://www.scopus.com/inward/record.url?scp=85069910260&partnerID=8YFLogxK
U2 - 10.3390/NCRNA5020031
DO - 10.3390/NCRNA5020031
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85069910260
SN - 2311-553X
VL - 5
JO - Non-coding RNA
JF - Non-coding RNA
IS - 2
M1 - 31
ER -